Aalberts: highlights ING Benelux Conference Brussels 2024, Ackermans & Van Haaren: Highlights ING Benelux Conference Brussels,Ackermans & Van Haaren: Strong operational performance of underlying companies and guidance fine-tuned upwards, AMG: Highlights ING Benelux Conference Brussels, Aperam: Highlights ING Benelux Conference Brussels, Arcadis: Highlights ING Benelux conference, Azelis: Highlights ING Benelux Conference Brussels, Bekaert: Guidance cut and €200m buyback as sweetener, CFE: No new...
A director at Agfa-Gevaert NV bought 80,000 shares at 0.681EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
The message at 3Q24 results is the same as in 1H24: residential sales in Belgium are moving forward, Luxembourgh RESI is at a standstill. Luckily there are almost no speculative developments in Nextensa's pipeline and its debt ratio is below 50%, at 45.6%. The average duration of the credit lines is short at 2.09y. However all FY24-1H25 maturing debts are renegotiated. The standing asset portfolio is performing well and gives comfort. The rental income increased vs 3Q23 despite divestments on th...
>Positive tone on Capital Markets Day - Last week Xior showcased its Basecamp portfolio in Copenhagen (Denmark) and Malmo (Sweden) during its Capital Markets Day. The company is close to solving its leverage issues, while issues pressuring the share price in 2022 and 2023 have been resolved. Highlights to us were the strong visibility on future like-for-like growth and the quality of its Basecamp product. We think the Xior platform is one of the best growth platforms...
Nextensa: Q3 RESULTS 2024 REGULATED INFORMATION Brussels, 14 November 2024, 5:40 PM Q3 RESULTS 2024 HIGHLIGHTS INVESTMENT PROPERTIES The rental income is €750K higher than in the third quarter of 2023 despite the strategic divestments of Hygge and Foetz in 2024. Realisation of a like-for-like rental growth on the entire portfolio of +2.94% in Q3 2024 compared to 2023. Decrease in property costs by 15% (€1.5 M) due to higher occupancy rates and the aforementioned divestments. DEVELOPMENT PROJECTS The result of the development projects is €0.6 M higher than in the same period last...
Nextensa: RÉSULTATS Q3 2024 INFORMATION RÉGLEMENTÉE Bruxelles, 14 novembre 2024, 17h40 RÉSULTATS Q3 2024 FAITS MARQUANTS IMMEUBLES DE PLACEMENT Les revenus locatifs sont supérieurs de 750K € à ceux du troisième trimestre 2023 malgré les désinvestissements stratégiques de Hygge et Foetz en 2024. Réalisation d’une croissance des loyers à périmètre constant sur l’ensemble du portefeuille de +2,94 % au Q3 2024 par rapport à 2023. Diminution des coûts immobiliers de 15 % (1,5 million d’euros) en raison de taux d’occupation plus élevés et des désinvestissements susmentionnés. PROJETS DE D...
Agfa-Geveart: Material miss on Healthcare activities. ASML: Long-term guidance confirmed. CVC Capital Partners: Comfortably on track. DEME Group: Raises outlook, lowers capex guidance. Proximus: Pressure on CEO from another possible coalition party. SBM Offshore: Again delivering
3Q24 numbers were below our and CSS forecasts. We will update our model but we already lower our Target Price from € 2.0 to € 1.4. 3Q24 sales came in at € 277m (KBCSe € 291, CSS 286) and 3Q24 REBIT was €4m (KBCSe € 8.1m, CSS € 7m) with especially a poor performance in Radiology Solutions. Agfa hinted at a strong profitability step up in Digital Printing and Chemicals, and a significant increase in order intake in HealthCare IT, with a high share of cloud-based and net new customer contracts. Thi...
The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 15 million euro - regulated information Regulated information November 14, 2024 - 7:45 a.m. CET The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 15 million euro The Agfa-Gevaert Group posted double-digit revenue growth and a strong profitability step up in Digital Printing and Chemicals, and a significant increase in order intake in HealthCare IT, with a high share of cloud-based and net new customer contracts. This was counterbalanced by an accelerated m...
De Agfa-Gevaert Groep in het derde kwartaal van 2024: stabiele omzet, aangepaste EBITDA van 15 miljoen euro - gereglementeerde informatie Gereglementeerde informatie 14-11-2024 - 7:45 uur CET De Agfa-Gevaert Groep in het derde kwartaal van 2024: stabiele omzet, aangepaste EBITDA van 15 miljoen euro De Agfa-Gevaert Groep noteerde een omzetgroei met dubbele cijfers en een sterke rendabiliteitsverbetering in Digital Printing and Chemicals, alsook een aanzienlijke toename van de order intake in HealthCare IT, met een groo...
Agfa kondigt plan aan om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de realiteit in de markt - gereglementeerde informatie 14 november 2024 – 7:45 uur CET Gereglementeerde informatie Agfa kondigt plan aan om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de realiteit in de markt Mortsel, België – 14 november 2024 – 7u45 Agfa kondigde vandaag een plan aan om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de realiteit in de markt. De onderneming heeft de intentie om alle aspecten van de filmgerelateerde...
Agfa announces plan to adjust the cost base of its traditional film activities to the reality in the market - regulated information November 14, 2024 – 7:45 a.m. CET Regulated information Agfa announces plan to adjust the cost base of its traditional film activities to the reality in the market Mortsel, Belgium – November 14, 2024 – 7:45 a.m. CET Agfa today announced a plan to adjust the cost base of its traditional film activities to the reality in the market. The company has the intention to thoroughly reorganize all aspects of the film-related...
We maintain our Outperform rating on CaixaBank, one of our Top Picks in the sector, with a higher target of € 7.2 vs € 6.7 and ahead of the CMD on 19 November. We are lifting our net income estimates by 7% for 2025-2026, to 7% above the consensus. The strategic update is set to highlight the wisdom of the business model diversification (long-term savings) to address the current transition phase on rates. Despite a solid market performance, the profile does not look to be fully reflec...
Nous réitérons notre opinion Surperformance sur CaixaBank, l’un de nos top picks du secteur, avec un OC porté à 7.2 € vs 6.7 € et en amont du CMD du 19/11. Nous relevons nos anticipations de RN de 7% sur 2025/2026 qui ressortent 7% supérieures au consensus. L’update stratégique devrait mettre en avant la pertinence de la diversification du business model (épargne LT) face à la transition actuelle sur les taux. Malgré un solide parcours boursier, cela n’est pas pleinement reflété dans ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.